| Date Filed | Type | Description |
| 02/01/2023 |
4
| Thornton Michael Milos (Chief Technology Officer) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 68,066 options
@ $4.02, valued at
$273.6k
|
|
| 12/13/2022 |
4
| Thornton Michael Milos (Chief Technology Officer) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Bought 1,500 shares
@ $3.4, valued at
$5.1k
|
|
| 08/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/30/2022 |
4
| Thornton Michael Milos (Chief Technology Officer) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 698,102 options
@ $0.38, valued at
$265.3k
|
|
| 09/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2020 |
4
| Thornton Michael Milos (Chief Technology Officer) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Converted 51,747 shares
@ $0.87, valued at
$45k
Converted 44 convertible preferred
@ $1143.68, valued at
$50k
|
|
| 04/13/2020 |
4
| Thornton Michael Milos (Chief Technology Officer) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 96,213 shares
@ $0 |
|
| 12/11/2019 |
4
| Thornton Michael Milos (Chief Technology Officer) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 575,906 options to buy
@ $0.9, valued at
$518.3k
Granted 44 convertible preferred
@ $1143.68, valued at
$50k
Granted 50,252 warrants
@ $0.87, valued at
$43.7k
|
|
| 05/20/2019 |
4
| Thornton Michael Milos (Chief Technology Officer) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Bought 30,000 shares
@ $1.13, valued at
$33.9k
|
|
| 12/17/2018 |
4
| Thornton Michael Milos (Chief Technology Officer) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 125,000 options
@ $2.25, valued at
$281.3k
|
|
| 11/15/2018 |
4
| Thornton Michael Milos (Chief Technology Officer) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Converted 29,762 shares
@ $1.68, valued at
$50k
Converted convertible notes
@ $1.68, valued at
$0 |
|
| 07/02/2018 |
4
| Thornton Michael Milos (Chief Technology Officer) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted convertible notes
@ $50000, valued at
$0
Granted 12,401 warrants
@ $2.52, valued at
$31.3k
|
|
| 06/28/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/23/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 05/16/2017 |
4
| Thornton Michael Milos (Chief Technology Officer) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Converted 55,020 shares
@ $1.4, valued at
$77k
Converted convertible notes
@ $1.4, valued at
$0
Granted 313,338 options
@ $5, valued at
$1.6M
|
|
| 05/16/2017 |
3
| Thornton Michael Milos (Chief Technology Officer) has filed a Form 3 on ENDRA Life Sciences Inc. |